“…Low levels of VitC and VitE, as well as other antioxidants, have been observed in plasma of individuals with Alzheimer’s disease and mild cognitive impairment ( Rinaldi et al, 2003 ; Mangialasche et al, 2012 ), which has led to the suggestion that supplementation with antioxidants could delay or reduce cognitive impairment. The results of the several trials that have already been carried out in the last decades failed to reach a consensus by the role of these vitamins in the treatment of aging and related disease ( Petersen et al, 2005 ; Goodman et al, 2011 ; Santilli et al, 2015 ; Basambombo et al, 2017 ; Monacelli et al, 2017 ; Ohlow et al, 2017 ). This can be due, at least in part, to the heterogeneity (e.g., genetic variations as well as differences in diet, lifestyle and environmental factors) of the human population and the difficulty in finding true controls ( Mocchegiani et al, 2014 ), as well as the inherent variability in amounts of VitE present in regular diets.…”